Calibr at Scripps Research
Joe Cahiwat has a diverse work experience spanning over several companies and roles. Joe is currently an Associate (Scientific) Director at Calibr at Scripps Research, a position they began in June 2021. Prior to this, they worked as a Senior Field Applications Scientist at Beckman Coulter Life Sciences from June 2020 to June 2021.
From 2015 to 2020, Joe was employed at Samumed, LLC, where they held various roles including Scientist in Discovery Biology, Compound Management Head, High-Throughput Screening, and Lab Automation. Before that, they worked at Novartis Institutes for BioMedical Research (NIBR) as a Scientific Associate II in the Compound Management Group from 2011 to 2015.
Furthermore, Joe has experience as a Scientific Associate II at GNF from 2010 to 2011, an Associate Research Scientist II at Exelixis from 2007 to 2010, an Associate Scientist at Ligand Pharmaceuticals from 1998 to 2007, and an Assistant Scientist at Synthetic Genetics in 1998.
Throughout their career, Joe has demonstrated expertise in compound management, high-throughput screening, lab automation, and various scientific assays. Joe has also managed databases and collaborated with different companies in the field.
Joe Cahiwat has a Bachelor of Science degree in Biology from UC San Diego. Additionally, they hold a Certification in Client/Server Technology with Visual Basic, Oracle, and SQL server from San Diego State University. Joe also obtained a Diploma from Duarte High School. There is no information provided about the start and end years for any of their education experiences. Joe also has an additional certification in Client/Server Technology with Visual Basic, Oracle, and SQL server from San Diego State University, but the exact month and year of obtaining this certification are unknown.
Calibr at Scripps Research
1 followers
The California Institute for Biomedical Research (Calibr) is a first-of-its-kind, nonprofit translational research institute dedicated to accelerating the next generation of medicines. Affiliated with Scripps Research—among the most innovative institutes worldwide—we spearhead drug discovery from a steady flow of pioneering science. Our self-sustaining model encourages broad and bold exploration with far-reaching goals, yet rapid transition of our most successful, high-impact programs into the clinic. We pursue audacious and imaginative ideas—bridging scientific and technological advances to develop new medicines for unmet medical needs. Our pipeline programs range from cancer to infectious diseases and from discovery to early clinical trial stages, all aimed at preventing disease and healing humans around the world. We bring together leaders in research, drug development, and business to answer important biological questions and develop new interventions to treat, cure, and prevent disease. Our infrastructure and expertise extend from high-throughput screening and protein engineering to pharmacology and clinical development. Calibr’s research space includes a newly renovated 35,000 square foot facility in La Jolla, CA, which houses over 100 interdisciplinary scientists and staff with state-of-the-art instrumentation. This infrastructure, combined with Calibr’s drug discovery expertise, enables projects rooted in novel therapeutic mechanisms to progress from the laboratory through preclinical development and ultimately to the clinic through commercial, federal, or foundation partnerships.